Elevance Health, Inc. (ELV) Stock Analysis

Company Overview

Elevance Health, Inc. operates as a health benefits company within the United States, delivering a comprehensive array of health plans and services tailored for both individual consumers and employer groups. The firm functions across four distinct segments—Health Benefits, CarelonRx, Carelon Services, and Corporate & Other—which collectively define its operational scope in the Healthcare sector under the specific industry of Healthcare Plans. This entity manages a substantial workforce of 96,129 employees, reflecting the labor-intensive nature of managing large-scale health insurance portfolios and administrative services. With a market capitalization of $63.21B and annual revenue reaching $199.13B, the company demonstrates significant scale that positions it as a major player in the national health insurance landscape, indicating deep market penetration and substantial economic impact within the industry.

Financial Health

The company reported revenue of $199.13B over the trailing twelve months, generating net income of $5.66B and EBITDA of $9.04B. The substantial gap between the $199.13B in revenue and the $5.66B in net income reveals a high-cost structure typical of the healthcare industry, where administrative expenses, claims payments, and regulatory costs consume a significant portion of top-line growth before reaching the bottom line. Operational efficiency is further highlighted by a free cash flow of $3.40B, which signifies the company's ability to generate liquidity after capital expenditures, providing financial flexibility for operational investments, debt servicing, or strategic acquisitions without relying on external financing. Profitability is analyzed through three key margins: a gross margin of 25.6% indicates the percentage of revenue remaining after direct costs, an operating margin of 1.5% reflects the efficiency of core business operations after internal costs, and a profit margin of 2.8% represents the final earnings relative to total sales. The balance sheet shows a cash position of $36.12B against total debt of $32.75B, while the debt-to-equity ratio stands at 74.39, suggesting a leveraged balance sheet where debt obligations are substantial relative to shareholder equity. Despite the leverage, the current ratio of 1.53 indicates that the company holds sufficient current assets to cover its current liabilities, pointing to adequate short-term liquidity to meet operational obligations. Management effectiveness is measured by a return on equity of 13.2% and a return on assets of 4.4%, metrics that reveal how efficiently the company utilizes shareholder capital and total assets to generate profits.

Valuation Assessment

Valuation metrics indicate that the stock trades with a P/E ratio of 11.36 on a trailing twelve-month basis and a forward P/E of 9.73. The difference between the trailing and forward P/E ratios implies that the market expects earnings growth in the future, as the forward multiple is lower than the trailing one, suggesting anticipated profitability expansion. The price-to-book ratio is 1.44, which indicates that the market values the company at a premium of 44% over its net asset book value, reflecting confidence in intangible assets like brand and customer base. Alternative valuation metrics include a price-to-sales ratio of 0.32 and an EV/EBITDA of 6.64, figures that suggest the stock is priced conservatively relative to its sales and earnings power compared to typical growth benchmarks. Price metrics show a 52-week high of $458.75 and a 52-week low of $273.71; without the current specific price in the provided facts, the range establishes the volatility band within which the stock has traded over the last year. The beta of 0.47 indicates that the stock's price volatility is significantly lower than the broader market, suggesting it is less sensitive to overall market fluctuations.

Growth & Income

Growth dynamics are defined by a revenue growth rate of 9.5% year-over-year and an earnings growth rate of 36.3% year-over-year. The fact that earnings are growing at a rate substantially faster than revenue implies that the company is improving its operational efficiency and cost structure, allowing net income to expand at a much quicker pace than top-line sales. As a dividend payer, the company offers a dividend yield of 2.4% with a payout ratio of 27.1%, indicating that the dividend is highly sustainable as it covers only a fraction of the generated earnings. This low payout ratio allows the firm to retain the majority of profits for reinvestment or debt reduction rather than distributing them entirely to shareholders. The overall profile combines double-digit revenue expansion with robust earnings acceleration, supported by a conservative cash position and a history of consistent dividend payments.